Intuitive Surgical, Inc. $ISRG Shares Bought by Apexium Financial LP

Apexium Financial LP grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% during the 2nd quarter, Holdings Channel.com reports. The firm owned 504 shares of the medical equipment provider’s stock after purchasing an additional 32 shares during the quarter. Apexium Financial LP’s holdings in Intuitive Surgical were worth $274,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. Quent Capital LLC boosted its stake in shares of Intuitive Surgical by 5.5% during the 2nd quarter. Quent Capital LLC now owns 1,428 shares of the medical equipment provider’s stock worth $776,000 after purchasing an additional 74 shares during the last quarter. QRG Capital Management Inc. lifted its holdings in shares of Intuitive Surgical by 4.8% during the 2nd quarter. QRG Capital Management Inc. now owns 78,672 shares of the medical equipment provider’s stock worth $42,751,000 after acquiring an additional 3,596 shares during the period. ZWJ Investment Counsel Inc. lifted its holdings in shares of Intuitive Surgical by 5.2% during the 2nd quarter. ZWJ Investment Counsel Inc. now owns 1,150 shares of the medical equipment provider’s stock worth $625,000 after acquiring an additional 57 shares during the period. Segment Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 6.2% during the 2nd quarter. Segment Wealth Management LLC now owns 5,552 shares of the medical equipment provider’s stock worth $3,017,000 after acquiring an additional 322 shares during the period. Finally, Precedent Wealth Partners LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth about $210,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 2.1%

ISRG stock opened at $452.35 on Friday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market capitalization of $162.16 billion, a P/E ratio of 63.09, a PEG ratio of 4.74 and a beta of 1.61. The firm has a 50 day simple moving average of $463.55 and a 200-day simple moving average of $500.06.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the company earned $1.78 earnings per share. The business’s quarterly revenue was up 21.4% compared to the same quarter last year. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at approximately $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages have recently weighed in on ISRG. Evercore ISI increased their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a report on Tuesday, July 8th. The Goldman Sachs Group cut their price objective on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a report on Wednesday. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Piper Sandler restated an “overweight” rating and issued a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Truist Financial raised their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $594.19.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.